The 2nd International mRNA Health Conference will bring together more than 150 attendees from leading international pharmaceutical and biotechnology companies and academic institutions.

learn more

CNBC recognizes Moderna as one of the top 10 companies whose innovations are having a dramatic impact across their industries.learn more

Alexion and Moderna have an exclusive strategic agreement for the discovery and development of messenger RNA Therapeutics™ for rare diseases.

learn more

Moderna announces a landmark publication describing the first-ever protein production through messenger RNA therapeutics™.

learn more

Moderna and AstraZeneca have a strategic option agreement to develop up to forty messenger RNA Therapeutics™ for the treatment of serious cardiometabolic diseases and cancer.

learn more

We are delivering the next wave of innovation to treat serious illness.

here's how


What's New

October 16, 2014

Moderna to Collaborate with Karolinska Institutet and Karolinska University | Read more

July 1, 2014

Moderna Appoints Oncology Leader Dr. Stephen Kelsey as President of Onkaido | Read more

June 17, 2014

Moderna Named to CNBC Disruptor 50 List | Read more